Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years
Clinical trial NCT04537793 · COMPLETED
Trial details
- NCT number
- NCT04537793
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2022-06-03
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.